Regulatory Expertise in Drug Development
Our team of regulatory experts offers comprehensive guidance across the entire spectrum of drug development, ensuring an optimal regulatory strategy tailored to your organization's needs. We prioritize thorough evaluations for your target labeling, potential orphan drug applications, and pediatric investigation plans, emphasizing environmental risk assessments to anticipate any impact on the environment well in advance of your marketing authorization application. With specialized knowledge and experience, our specialists are equipped to support you at every stage, offering invaluable guidance along the way.



Our regulatory experts offer guidance on drug development and regulatory strategy, ensuring your organization navigates the regulatory landscape effectively. Detailed analysis reports outlining regulatory pathways, risk assessments, and strategic recommendations tailored to your organization's needs.

We assist clients in obtaining and maintaining wholesale dealers' licenses and parallel importers' licenses across the EU, facilitating compliant distribution. License applications, compliance audits, and regulatory correspondence.

Our dynamic team offers tailored pharmacovigilance services, ensuring compliance with safety monitoring requirements and enhancing patient safety. Pharmacovigilance plans, adverse event reporting documentation, and risk management plans.

Our outsourcing services provide flexible regulatory support for short or long-term projects, ensuring continuity during periods of transition or resource gaps. Outsourcing agreements, project timelines, and interim management reports.

We prepare comprehensive Chemistry, Manufacturing, and Controls (CMC) dossiers, IMPDs, and CPPs, ensuring regulatory compliance for product development. CMC regulatory submissions, manufacturing process descriptions, and quality control documentation.

We prepare comprehensive submission documents tailored to specific regulatory requirements, facilitating market access in different regions. Country-specific dossier compilations, regulatory submission forms, and linguistic translations.

With extensive global experience, we facilitate interactions with regulatory agencies worldwide, ensuring compliance with local regulations. Agency correspondence records, regulatory filing documentation, and global regulatory strategy reports.

Our team manages communication with regulatory agencies on behalf of your company, ensuring timely responses and compliance with requirements. Regulatory correspondence logs, agency meeting minutes, and submission cover letters.

Our experienced team provides support throughout the merger, divestment, and acquisition process, ensuring regulatory compliance and smooth transitions. Regulatory integration plans, divestment agreements, and acquisition due diligence reports.

We conduct regulatory due diligence to identify risks and gaps, facilitating informed decision-making for mergers, acquisitions, and partnerships. Due diligence reports, risk assessments, and gap analysis summaries.

Our panel of certified Qualified Persons (QPs) offers expertise for short and long-term assignments, ensuring compliance with regulatory requirements. QP appointment documentation, batch release reports, and regulatory compliance certificates.

Our skilled teams offer tailored training sessions on various regulatory topics, empowering your staff with regulatory knowledge and expertise. Training materials, presentations, and regulatory compliance manuals.

We provide comprehensive support to prepare companies for Brexit scenarios, minimizing regulatory disruptions and ensuring continuity. Brexit impact assessments, contingency plans, and regulatory compliance checklists.

We assist in identifying key challenges and technical questions, facilitating discussions with regulatory authorities to ensure regulatory compliance. Scientific advice meeting summaries, regulatory correspondence records, and technical briefing documents.

We leverage our experience to develop Standard Operating Procedures (SOPs) across regulatory and quality areas, ensuring consistency and compliance. SOP manuals, process flowcharts, and SOP training modules.

Our in-house capabilities support the electronic submission of regulatory documents, streamlining the submission process. eCTD-compliant dossier compilations, electronic submission-ready documents, and validation reports.

Patient readability testing ensures comprehension of informational materials, enhancing patient safety and compliance. User testing protocols, readability test results, and revised patient information leaflets.

With our representation services, companies outside the EU can seamlessly navigate regulatory processes within the region. Representation agreements, regulatory liaison documentation, and compliance reports for non-EU sponsors.

We provide accurate and compliant labeling, Summary of Product Characteristics (SmPCs), and medical writing services to meet regulatory requirements. Labeling templates, SmPC drafts, patient information leaflets, and clinical study reports.

We manage all aspects of Marketing Authorization Applications (MAA), from initial submissions to post-approval support, ensuring compliance with regulations throughout the product lifecycle. Documentation including regulatory submissions, variations, and renewal applications, as well as ongoing compliance reports and updates.

Our team handles the preparation and submission of Clinical Trial Applications (CTA) to Health Authorities and Ethics Committees, ensuring timely approvals. CTA submissions, protocol summaries, informed consent forms, and regulatory correspondence.

Linguistic Translations
Our team of specialized pharmaceutical translators boasts extensive experience in the pharmaceutical industry, ensuring that your translated materials maintain the same level of attention to detail as the original content. We offer comprehensive support throughout the drug development, launch, and lifecycle processes, serving as your full-service partner.
In addition to adhering to industry guidelines and templates, our pharmaceutical translation teams utilize standardized specialist terminology and dictionaries in their work. Our expert in-house Account Managers possess a wealth of industry knowledge, guaranteeing professional and efficient handling of your projects.

CBD Products and e-Cigarettes (Cannabidiol (CBD) Products)
In 2016, the UK's regulatory agency, The MHRA, classified products containing cannabidiol (CBD) with more than 0.01% THC for medical purposes as medicines. All medicinal products must hold a valid product license (marketing authorization) before legal sale, supply, or advertisement in the UK. Licensed medicinal products must meet safety, quality, and efficacy standards to safeguard public health.
General rules for marketing CBD products in the UK, not requiring MHRA authorization, dictate that labels must avoid medical claims, disclose CBD content, provide full manufacturer details, and list all ingredients. Crucially, products must contain no more than 0.01% THC.
Furthermore, regulatory authorities in EU member states now classify any food, drink, or food supplements containing CBD as "novel food." All novel foods containing CBD necessitate marketing authorization. Therefore, any company intending to incorporate CBD into food must apply to the European Commission before marketing the product.
Examples of CBD foods subject to novel food regulations include CBD oils, capsules, or oral sprays, CBD-infused gummies, mints, or other confections, as well as CBD tea, coffee, alcoholic and non-alcoholic beverages, and any CBD-infused snacks like crisps or energy bars. Oxygen Life Sciences offers consulting services to ensure compliance with all CBD regulations, facilitating the legal entry of your CBD-containing products into the UK/EU market.

E-Cigarettes
Oxygen Life Sciences provides comprehensive regulatory guidance on e-cigarette registration. Our experienced consultants specialize in the Tobacco Products Directive (TPD). Enforced from May 2016, the TPD introduced new regulations for nicotine-containing electronic cigarettes and refill containers (Article 20).
Our TPD consultants possess backgrounds in pharmaceutical regulation. Given that e-cigarette regulation aligns with pharmaceutical regulation, consultants with expertise in medical regulatory affairs are best suited to advise on emerging e-cigarette regulations.
If you're an importer or manufacturer of e-cigarettes or e-liquids, your products must comply with TPD regulations before selling in the EU. Contact us to learn how we can assist you in legally registering your products for sale in the EU.